Translate

ELS MALALTS RENALS EN ALTITUD

ALTITUD: MALALTIES RENALS, INSUFICIÈNCIA RENAL CRÒNICA, DIÀLISI I MORTALITAT

Normalment associem l'altitud amb molts trastorns i malalties, ja sigui produïdes directament per l'altitud o sigui perqué empitjorin trastorns preexistents. En tot cas, sembla que l'altitud té mala premsa entre metges i pacients. Sembla que només alpinistes i altres personatges de reconeguda capacitat i resistència poden enfrontar-se a un ambient tan hostil.
No sempre, peró, és així. Ja hem vist que els sanatoris de les malalties respiratòries han estat tradicionalment localitzats a zones de muntanya i actualment sabem que l'asma pot millorar amb l'aclimatació.
Presentem un estudi del sistema epidemiològic públic dels Estats Units d'Amèrica, en que troben que els pacients amb insuficiència renal sotmesos a diàlisi, tenen major supervivència a altituds superiors a 1800 metres, mentre que els qui viuen a nivell del mar presenten major mortalitat sigui quina sigui la causa de la mort.
Sembla que aixó de l'altitud, com passa amb totes les monedes d'aquest mòn, deu tenir també una cara i una creu.


Publicat a: Journal of American Medical Association. JAMA. 2009 Feb 4;301(5):508-12.

ALTITUDE AND ALL-CAUSE MORTALITY IN INCIDENT DIALYSIS PATIENTS
Winkelmayer WC, Liu J, Brookhart MA.
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, Ste 3-030, Boston, MA 02120, USA. wwinkelmayer@partners.org

ABSTRACT: Patients undergoing dialysis at higher altitude receive lower erythropoietin doses, yet achieve higher hemoglobin concentrations. Increased iron availability caused by activation of hypoxia-induced factors at higher altitude may explain this finding. Hypoxia-induced factors are also involved in other pathways that may affect morbidity and mortality. 
OBJECTIVE: To study whether mortality differed by altitude in patients initiating dialysis. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort of patients initiating dialysis in the United States between 1995 and 2004. Patients were stratified by the average elevation of their residential zip code. Covariates included age, sex, race, Medicaid coverage, dialysis modality, comorbidities, and reported laboratory measurements. We constructed proportional hazards models of all-cause mortality, stratifying by year, and censoring patients at 5 years from first dialysis, at the end of the database (December 31, 2004), or loss to follow-up. We also compared age- and sex-adjusted standardized mortality rates of US patients receiving dialysis with the general population. 
MAIN OUTCOME MEASURE: Mortality from any cause. 
RESULTS: A total of 804 812 patients initiated dialysis and were followed up for a median of 1.78 years. Crude mortality rates per 1000 person-years were 220.1 at an altitude lower than 76 m (<250 ft), 221.2 from 76 through 609 m (250-1999 ft), 214.6 from 610 through 1218 m (2000-3999 ft), 184.9 from 1219 through 1828 m (4000 to 5999 ft), and 177.2 at an altitude higher than 1828 m (>6000 ft). After multivariable adjustment, compared with patients living at an altitude of lower than 76 m, the relative mortality rates were 0.97 (95% confidence interval [CI], 0.96-0.98) for those living from 76 through 609 m; 0.93 (95% CI, 0.91-0.95), from 610 through 1218 m; 0.88 (95% CI, 0.84-0.91), from 1219 through 1828 m, and 0.85 (95% CI, 0.79-0.92) higher than 1828 m. Age- and sex-standardized mortality decreased more with altitude in patients receiving dialysis than in the general population. 
CONCLUSIONS: Altitude was inversely associated with all-cause mortality among US patients receiving dialysis.

Etiquetes: , ,
edit

Cap comentari:

Publica un comentari a l'entrada

Si us plau, si voleu realitzar una consulta, aneu al formulari corresponent. Gràcies.

Vols fer una consulta?

Nom

Correu electrònic *

Missatge *

Subscriu-te per correu electrònic